--- title: CDMOs offering Oral Solid Dosage Manufacturing with Biologics (Other) path: /explore/oral-solid-dosage/biologics-other companies_count: 20 --- # CDMOs offering Oral Solid Dosage Manufacturing with Biologics (Other) 20 published CDMOs match Oral Solid Dosage Manufacturing and Biologics (Other). Locations in this set include United States, India, Italy, United Kingdom, China, and Canada. Capabilities that show up most often in this set: Sterile Fill-Finish & Aseptic Manufacturing, CMC Analytical Development, Formulation Development, Process Development, and Technology Transfer. ## Matching companies - [AbbVie Contract Manufacturing](/companies/abbviecontractmfg) - Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe. - [Aenova Group](/companies/aenova-group) - Aenova Group is a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry, offering solid dosage, sterile, semi-solid, and softgel manufacturing across multiple European and North American facilities. - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Ardena](/companies/ardena) - Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances. - [Ascendia Pharmaceutical Solutions](/companies/ascendiacdmo) - Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol. - [Asymchem Laboratories](/companies/asymchem) - Asymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry. - [BSP Pharmaceuticals](/companies/bsppharmaceuticals) - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply. - [Burrard Pharmaceuticals](/companies/burrardpharma) - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [CordenPharma](/companies/cordenpharma) - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees. - [Delpharm](/companies/delpharm) - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually. - [Dr. Reddy's Laboratories](/companies/drreddys) - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing. - [Lupin Limited](/companies/lupin) - Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure. - [Patheon (Thermo Fisher Pharma Services)](/companies/patheon) - Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing. - [Pfizer CentreOne](/companies/pfizercentreone) - Award-winning CDMO specializing in commercial manufacturing of oral solids, sterile injectables, and biologic drug products with Pfizer's technical expertise and global network. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Piramal Pharma Solutions](/companies/piramalpharmasolutions) - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management. - [ROIS](/companies/rovi-pharma-industrial-services) - Sterile fill-finish CDMO for biologics, vaccines and ADCs, offering prefilled syringes, cartridges and vials across five US and European sites. It also supports oral solid dose manufacturing and drug substance development. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.